11:15 IST
BSE
Other Announcement
Aurobindo Pharma Other Announcement
Aurobindo Pharma dispatched letters to shareholders without registered email IDs. These letters provide a web link to the Integrated Annual Report 2025-26.
Aurobindo Pharma Ltd
Aurobindo Pharma Ltd news stories on ALFA NewsRead the news →- Share price
- ₹1,680.80
- Market cap
- ₹97,621 Cr
- Revenue (annual)
- ₹33,653 Cr
- Net profit (annual)
- ₹3,505 Cr
- P/E (TTM)
- 24.8×Sector 47.4×
- Promoter holding
- 51.88%+0.06% QoQ
- FII holding
- 16.38%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Merger & Restructuring 16Regulatory Approval 9Business Update 8Management Change 4Earnings Call 4Financial Results 3Other Announcement 2Board Meeting Date 2Annual General Meeting 2Results Update 1Production Started 1Product Launch 1Legal & Regulatory 1Debt & Borrowing 1Capacity Expansion 1Board Meeting Outcome 1Annual Report 1Adverse Business Impact 1Acquisition 1
Time
2 announcements with these filters
20:53 IST
BSE
Other Announcement
Aurobindo Pharma Other Announcement
Aurobindo Pharma appointed M/s. RPR & Associates as Secretarial Auditor for five years following M/s. MRR & Associates' resignation. The transition is due to proprietor health issues.
- Execution
- 5 years